SCHEMBL2985408

SCHEMBL2985408

CN(C)C1(Cc2ccc(Cl)cc2)CCC(NC(=O)COCc2ccccc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SIGMAR1 Q99720 1/20 0.45
OPRM1 P35372 1/20 0.45
OPRL1 P41146 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 1/20 0.43
ATF4 P18848 1/20 0.43
MCHR1 Q99705 1/20 0.42
GRM5 P41594 1/20 0.42
POLB P06746 2/20 0.41
ATM Q13315 1/20 0.41
GRM7 Q14831 1/20 0.40
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2985875 0.91 OPRM1 (0.46) MEN1KMT2AOPRM1OPRL1L3MBTL1
SCHEMBL2987025 0.90 SIGMAR1 (0.47) SIGMAR1OPRM1OPRL1L3MBTL1MCHR1
SCHEMBL2985836 0.87 SIGMAR1 (0.46) MEN1KMT2ASIGMAR1OPRM1OPRL1
SCHEMBL2987483 0.87 ATF4 (0.61) MEN1KMT2ALMNAATF4MCHR1
SCHEMBL2979269 0.84 LMNA (0.44) MEN1KMT2ANPSR1LMNAATF4
SCHEMBL2985108 0.84 OPRM1 (0.45) MEN1KMT2AOPRM1OPRL1L3MBTL1
SCHEMBL2978761 0.83 ATF4 (0.65) MEN1KMT2AL3MBTL1LMNAATF4
SCHEMBL2976479 0.82 OPRM1 (0.52) MEN1KMT2ANPSR1OPRM1OPRL1
SCHEMBL2985450 0.82 OPRM1 (0.47) MEN1KMT2AOPRM1OPRL1L3MBTL1
SCHEMBL2985973 0.82 ALDH1A1 (0.49) MEN1KMT2ASIGMAR1OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786328-B2 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2010-08-31 US claimed
JP-2007536322-A 2007-12-13 JP claimed
US-20070281954-A1 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-12-06 US claimed
EP-1747191-A1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES WITH A CHAIN EXTENSION Grünenthal GmbH (DE) 2007-01-31 EP claimed
WO-2005110975-A1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES WITH A CHAIN EXTENSION Grünenthal GmbH (DE) 2005-11-24 WO claimed
US-7786328-B2 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2010-08-31 US disclosed
US-20070281954-A1 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281954-A1 Cyclohexyl-1,4-diamine compounds DPYD, PKD1, AOC1 MEN1 318/4885KMT2A 3786/4885NPSR1 1311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.